Example of Medical Microbiology and Immunology format
Recent searches

Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format Example of Medical Microbiology and Immunology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Medical Microbiology and Immunology — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Microbiology (medical) #40 of 116 down down by 12 ranks
Immunology and Allergy #92 of 182 down down by 16 ranks
Immunology #117 of 202 down down by 29 ranks
journal-quality-icon Journal quality:
Good
calendar-icon Last 4 years overview: 203 Published Papers | 941 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 17/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

Taylor and Francis

Quality:  
High
CiteRatio: 8.4
SJR: 2.078
SNIP: 1.475
open access Open Access
recommended Recommended

Nature

Quality:  
High
CiteRatio: 28.2
SJR: 7.305
SNIP: 3.41
open access Open Access
recommended Recommended

Nature

Quality:  
High
CiteRatio: 53.9
SJR: 20.529
SNIP: 8.97
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 6.5
SJR: 1.812
SNIP: 1.485

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

1.961

34% from 2018

Impact factor for Medical Microbiology and Immunology from 2016 - 2019
Year Value
2019 1.961
2018 2.96
2017 3.202
2016 3.093
graph view Graph view
table view Table view

4.6

2% from 2019

CiteRatio for Medical Microbiology and Immunology from 2016 - 2020
Year Value
2020 4.6
2019 4.7
2018 6.6
2017 5.3
2016 4.7
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 34% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has decreased by 2% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.954

11% from 2019

SJR for Medical Microbiology and Immunology from 2016 - 2020
Year Value
2020 0.954
2019 0.86
2018 1.395
2017 1.287
2016 1.289
graph view Graph view
table view Table view

0.916

26% from 2019

SNIP for Medical Microbiology and Immunology from 2016 - 2020
Year Value
2020 0.916
2019 0.727
2018 0.966
2017 0.864
2016 0.753
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 11% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 26% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Medical Microbiology and Immunology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Medical Microbiology and Immunology

Medical Microbiology and Immunology publishes articles on all aspects of the interrelationship between infectious agents and their hosts. Major topics covered by the journal relate to pathogenesis of infections and immune-mediated diseases. Both clinical and basic research pap...... Read More

Medicine

i
Last updated on
16 Jul 2020
i
ISSN
0300-8584
i
Impact Factor
Very High - 3.093
i
Acceptance Rate
Not provided
i
Frequency
Not provided
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
SPBASIC
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1007/S00430-009-0116-7
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Abstract:

Antibodies are important tools for experimental research and medical applications. Most antibodies are composed of two heavy and two light chains. Both chains contribute to the antigen-binding site which is usually flat or concave. In addition to these conventional antibodies, llamas, other camelids, and sharks also produce a... Antibodies are important tools for experimental research and medical applications. Most antibodies are composed of two heavy and two light chains. Both chains contribute to the antigen-binding site which is usually flat or concave. In addition to these conventional antibodies, llamas, other camelids, and sharks also produce antibodies composed only of heavy chains. The antigen-binding site of these unusual heavy chain antibodies (hcAbs) is formed only by a single domain, designated VHH in camelid hcAbs and VNAR in shark hcAbs. VHH and VNAR are easily produced as recombinant proteins, designated single domain antibodies (sdAbs) or nanobodies. The CDR3 region of these sdAbs possesses the extraordinary capacity to form long fingerlike extensions that can extend into cavities on antigens, e.g., the active site crevice of enzymes. Other advantageous features of nanobodies include their small size, high solubility, thermal stability, refolding capacity, and good tissue penetration in vivo. Here we review the results of several recent proof-of-principle studies that open the exciting perspective of using sdAbs for modulating immune functions and for targeting toxins and microbes. read more read less

Topics:

Single-domain antibody (55%)55% related to the paper
View PDF
565 Citations
open accessOpen access Journal Article DOI: 10.1007/S00430-004-0219-0
Stability and inactivation of SARS coronavirus

Abstract:

The SARS-coronavirus (SARS-CoV) is a newly emerged, highly pathogenic agent that caused over 8,000 human infections with nearly 800 deaths between November 2002 and September 2003. While direct person-to-person transmission via respiratory droplets accounted for most cases, other modes have not been ruled out. Faecal shedding... The SARS-coronavirus (SARS-CoV) is a newly emerged, highly pathogenic agent that caused over 8,000 human infections with nearly 800 deaths between November 2002 and September 2003. While direct person-to-person transmission via respiratory droplets accounted for most cases, other modes have not been ruled out. Faecal shedding is common and prolonged and has caused an outbreak in Hong Kong. We studied the stability of SARS-CoV under different conditions, both in suspension and dried on surfaces, in comparison with other human-pathogenic viruses, including human coronavirus HCoV-229E. In suspension, HCoV-229E gradually lost its infectivity completely while SARS-CoV retained its infectivity for up to 9 days; in the dried state, survival times were 24 h versus 6 days. Thermal inactivation at 56°C was highly effective in the absence of protein, reducing the virus titre to below detectability; however, the addition of 20% protein exerted a protective effect resulting in residual infectivity. If protein-containing solutions are to be inactivated, heat treatment at 60°C for at least 30 min must be used. Different fixation procedures, e.g. for the preparation of immunofluorescence slides, as well as chemical means of virus inactivation commonly used in hospital and laboratory settings were generally found to be effective. Our investigations confirm that it is possible to care for SARS patients and to conduct laboratory scientific studies on SARS-CoV safely. Nevertheless, the agent’s tenacity is considerably higher than that of HCoV-229E, and should SARS re-emerge, increased efforts need to be devoted to questions of environmental hygiene. read more read less

Topics:

Infectivity (54%)54% related to the paper, Coronavirus (52%)52% related to the paper
View PDF
491 Citations
Journal Article DOI: 10.1007/S004300050071
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain

Abstract:

We assessed whether the intracellular bacterium Chlamydia pneumoniae was present in post-mortem brain samples from patients with and without late-onset Alzheimer's disease (AD), since some indirect evidence seems to suggest that infection with the organism might be associated with the disease. Nucleic acids prepared from thos... We assessed whether the intracellular bacterium Chlamydia pneumoniae was present in post-mortem brain samples from patients with and without late-onset Alzheimer's disease (AD), since some indirect evidence seems to suggest that infection with the organism might be associated with the disease. Nucleic acids prepared from those samples were screened by polymerase chain reaction (PCR) assay for DNA sequences from the bacterium, and such analyses showed that brain areas with typical AD-related neuropathology were positive for the organism in 17/19 AD patients. Similar analyses of identical brain areas of 18/19 control patients were PCR-negative. Electron- and immunoelectron-microscopic studies of tissues from affected AD brain regions identified chlamydial elementary and reticulate bodies, but similar examinations of non-AD brains were negative for the bacterium. Culture studies of a subset of affected AD brain tissues for C. pneumoniae were strongly positive, while identically performed analyses of non-AD brain tissues were negative. Reverse transcription (RT)-PCR assays using RNA from affected areas of AD brains confirmed that transcripts from two important C. pneumoniae genes were present in those samples but not in controls. Immunohistochemical examination of AD brains, but not those of controls, identified C. pneumoniae within pericytes, microglia, and astroglia. Further immunolabelling studies confirmed the organisms' intracellular presence primarily in areas of neuropathology in the AD brain. Thus, C. pneumoniae is present, viable, and transcriptionally active in areas of neuropathology in the AD brain, possibly suggesting that infection with the organism is a risk factor for late-onset AD. read more read less

Topics:

Neuropathology (53%)53% related to the paper
471 Citations
Journal Article DOI: 10.1007/S00430-014-0369-7
Natural history of chronic hepatitis B virus infection
Katrin Busch1, Robert Thimme1

Abstract:

Hepatitis B virus infection represents a major global health problem. Currently, there are more than 240 million chronically infected people worldwide. The development of chronic hepatitis B virus-mediated liver disease may lead to liver fibrosis, cirrhosis and eventually hepatocellular carcinoma. Recently, the discovery of t... Hepatitis B virus infection represents a major global health problem. Currently, there are more than 240 million chronically infected people worldwide. The development of chronic hepatitis B virus-mediated liver disease may lead to liver fibrosis, cirrhosis and eventually hepatocellular carcinoma. Recently, the discovery of the viral entry receptor sodium taurocholate cotransporting polypeptide has facilitated new approaches for a better understanding of viral physiopathology. Hopefully, these novel insights may give rise to the development of more effective antiviral therapy concepts during the next years. In this review, we will discuss the natural history of hepatitis B virus infection including the viral biology, the clinical course of infection and the role of the immune response. read more read less

Topics:

Hepatitis B (67%)67% related to the paper, Hepatitis B virus (60%)60% related to the paper, Liver disease (58%)58% related to the paper, Viral entry (57%)57% related to the paper, Oncovirus (55%)55% related to the paper
459 Citations
Journal Article DOI: 10.1007/BF02123572
Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin.
K. Tobita, A. Sugiura, C. Enomoto, M. Furuyama

Abstract:

A wide variety of influenza A viruses, comprising human, equine, porcine, and avian strains, grew productively in an established line of canine kidney cells (MDCK) under an overlay medium containing trypsin, and formed well-defined plaques regardless of their prior passage history. Plaquing efficiency was comparable to the ef... A wide variety of influenza A viruses, comprising human, equine, porcine, and avian strains, grew productively in an established line of canine kidney cells (MDCK) under an overlay medium containing trypsin, and formed well-defined plaques regardless of their prior passage history. Plaquing efficiency was comparable to the efficiency of infection in fertile eggs via allantoic route. MDCK cells have also been successfully employed for the primary isolation of influenza A virus from throat washings of patients. Parallel titration of several clinical specimens showed that the inoculation into MDCK cells followed by incubation in the presence of trypsin was an isolation procedure as sensitive as the amniotic inoculation into fertile eggs. read more read less

Topics:

Influenza A virus (56%)56% related to the paper, Viral Plaque Assay (54%)54% related to the paper, Virus quantification (52%)52% related to the paper
412 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Medical Microbiology and Immunology.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Medical Microbiology and Immunology format uses SPBASIC citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Medical Microbiology and Immunology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Medical Microbiology and Immunology guidelines and auto format it.

2. Do you follow the Medical Microbiology and Immunology guidelines?

Yes, the template is compliant with the Medical Microbiology and Immunology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Medical Microbiology and Immunology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Medical Microbiology and Immunology citation style.

4. Can I use the Medical Microbiology and Immunology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Medical Microbiology and Immunology.

5. Can I use a manuscript in Medical Microbiology and Immunology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Medical Microbiology and Immunology that you can download at the end.

6. How long does it usually take you to format my papers in Medical Microbiology and Immunology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Medical Microbiology and Immunology.

7. Where can I find the template for the Medical Microbiology and Immunology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Medical Microbiology and Immunology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Medical Microbiology and Immunology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Medical Microbiology and Immunology an online tool or is there a desktop version?

SciSpace's Medical Microbiology and Immunology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Medical Microbiology and Immunology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Medical Microbiology and Immunology?”

11. What is the output that I would get after using Medical Microbiology and Immunology?

After writing your paper autoformatting in Medical Microbiology and Immunology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Medical Microbiology and Immunology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Medical Microbiology and Immunology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Medical Microbiology and Immunology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Medical Microbiology and Immunology?

The 5 most common citation types in order of usage for Medical Microbiology and Immunology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Medical Microbiology and Immunology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Medical Microbiology and Immunology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Medical Microbiology and Immunology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Medical Microbiology and Immunology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Medical Microbiology and Immunology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template